Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04202419 · ClinicalTrials.gov registry record · NA
Nonablative Fractional Diode Laser for Treatment of Pigmented Lesions
A NA study, sponsored by Candela Corporation.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04202419 is a NA study that has completed, run by Candela Corporation. The registered enrollment target is 30 participants.
The verdict
NCT04202419, a NA study, has completed, sponsored by Candela Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate the safety and efficacy of a fractional diode laser for treatment of pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sunspots), and ephelides (freckles).
Interventions
- DEVICE FRAX 1940 nm laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-01-09 |
| Est. Completion | 2021-04-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04202419
The ClinicalTrials.gov registry entry for NCT04202419 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Candela Corporation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FRAX 1940 nm laser is the first listed.
NCT04202419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04202419 about?
NCT04202419 is a clinical study titled "Nonablative Fractional Diode Laser for Treatment of Pigmented Lesions". This study is being conducted to evaluate the safety and efficacy of a fractional diode laser for treatment of pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sunspots), and ephelides (freckles).
What is the current status of trial NCT04202419?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-01-09. Estimated completion is 2021-04-26.
What interventions are being tested in trial NCT04202419?
The interventions under investigation include: FRAX 1940 nm laser (DEVICE).
Who is sponsoring clinical trial NCT04202419?
This trial is sponsored by Candela Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.